Features

Research on aging treatments keeps turning up profound variations in how male and female subjects respond.

A CRISPR startup rewrites tiny mutations instead of cutting and pasting entire genes.

Student competitors turn jellyfish, microorganisms, and even hair cells into useful things.

Investors and families are counting on Onno Faber to galvanize research into neglected conditions—like the one threatening his hearing and sight.

Women suffering from hot flashes try to find relief in a device that wasn’t designed specifically for them.

A startup tries to scale up health care that’s cheaper, safer, and much more comfortable.

“The Rise of Yeast” explains how one fungus altered history.

An engineer lights up tiny tumors that doctors can’t see.

Elite athletes are now maintaining their level of performance in their 40s and beyond. What can they teach the rest of us?

A review of three devices: SleepScore Max, Eight Sleep, and Dreem.

Forget what you may have heard about neural networks in software. This startup is making a computer with living neurons.

Genes play a refreshingly limited role in Carl Zimmer’s new book about heredity.

Michael Pollan explores the neuroscience of psychedelics in this excerpt from his new book.

A startup finds patterns that experts in personalized medicine say they couldn’t see before.

Billionaire Jim Mellon bets that a “stock market mania” will be sparked by technologies that make people live past 100.